APA način citiranja

Wu, Y., Fan, Y., Dong, D., Dong, X., Hu, Y., Shi, Y., . . . Li, E. (2020). Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: An adjusted indirect meta-analysis and systematic review. Ther Adv Med Oncol.

Čikaški stil citiranja

Wu, Yinying, Yangwei Fan, Danfeng Dong, Xuyuan Dong, Yuan Hu, Yu Shi, Jiayu Jing, i Enxiao Li. "Efficacy and Safety of Regorafenib As Beyond Second-line Therapy in Patients With Metastatic Colorectal Cancer: An Adjusted Indirect Meta-analysis and Systematic Review." Ther Adv Med Oncol 2020.

MLA način citiranja

Wu, Yinying, et al. "Efficacy and Safety of Regorafenib As Beyond Second-line Therapy in Patients With Metastatic Colorectal Cancer: An Adjusted Indirect Meta-analysis and Systematic Review." Ther Adv Med Oncol 2020.